Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China.
College of Life Sciences, Henan Normal University, Xinxiang, 453007, China.
Sci Rep. 2021 Feb 3;11(1):2936. doi: 10.1038/s41598-020-80314-0.
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has caused a global pandemics. To facilitate the detection of SARS-CoV-2 infection, various RT-LAMP assays using 19 sets of primers had been developed, but never been compared. We performed comparative evaluation of the 19 sets of primers using 4 RNA standards and 29 clinical samples from COVID-19 patients. Six of 15 sets of primers were firstly identified to have faster amplification when tested with four RNA standards, and were further subjected to parallel comparison with the remaining four primer sets using 29 clinical samples. Among these 10 primer sets, Set-4 had the highest positive detection rate of SARS-CoV-2 (82.8%), followed by Set-10, Set-11, and Set-13 and Set-17 (75.9%). Set-14 showed the fastest amplification speed (Tt value < 8.5 min), followed by Set-17 (Tt value < 12.5 min). Based on the overall detection performance, Set-4, Set-10, Set-11, Set-13, Set-14 and Set-17 that target Nsp3, S, S, E, N and N gene regions of SARS-CoV-2, respectively, were determined to be better than the other primer sets. Two RT-LAMP assays with the Set-4 primers in combination with any one of four other primer sets (Set-14, Set-10, Set-11, and Set-13) were recommended to be used in the COVID-19 surveillance.
新型冠状病毒病(COVID-19)由 SARS-CoV-2 引起,已在全球范围内引发大流行。为了便于检测 SARS-CoV-2 感染,已经开发了各种使用 19 组引物的 RT-LAMP 检测方法,但从未进行过比较。我们使用 4 个 RNA 标准品和 29 份来自 COVID-19 患者的临床样本对这 19 组引物进行了比较评估。在测试 4 个 RNA 标准品时,首先鉴定出 15 组引物中的 6 组具有更快的扩增速度,然后使用 29 个临床样本对其余 4 组引物进行了平行比较。在这 10 组引物中,Set-4 对 SARS-CoV-2 的阳性检出率最高(82.8%),其次是 Set-10、Set-11、Set-13 和 Set-17(75.9%)。Set-14 的扩增速度最快(Tt 值<8.5 min),其次是 Set-17(Tt 值<12.5 min)。根据总体检测性能,分别针对 SARS-CoV-2 的 Nsp3、S、S、E、N 和 N 基因区域的 Set-4、Set-10、Set-11、Set-13、Set-14 和 Set-17 引物组被确定优于其他引物组。建议使用包含 Set-4 引物的两种 RT-LAMP 检测方法,并与其他 4 种引物组(Set-14、Set-10、Set-11 和 Set-13)中的任意一种联合使用,以进行 COVID-19 监测。